Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

TFX
TeleflexTFX
-$44.99M+24.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$6.29M-190%
PDE
Pro-Dex, Inc.PDEX
-$5M-6,751%
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
-$27.64M-358%
UFP Technologies logo
UFP TechnologiesUFPT
-$1.62M+84.9%
Medline, Inc. logo
Medline, Inc. MDLN
-$13M-44.4%

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's cash provided by (used in) financing activity, including discontinued operation?
Utah Medical Products (UTMD) reported cash provided by (used in) financing activity, including discontinued operation of -$1.12M in Q1 2026.
How has Utah Medical Products's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
Utah Medical Products's cash provided by (used in) financing activity, including discontinued operation increased by 73.6% year-over-year, from -$4.24M to -$1.12M.
What is the long-term trend for Utah Medical Products's cash provided by (used in) financing activity, including discontinued operation?
Over 4 years (2021 to 2025), Utah Medical Products's cash provided by (used in) financing activity, including discontinued operation has grown at a 3.1% compound annual growth rate (CAGR), from -$10.91M to -$12.34M.
What does cash provided by (used in) financing activity, including discontinued operation mean?
This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.